CONDOL01: Evaluation on the Experience of Bereavement, of a Medical Consultation, Proposed by a Letter of CONDOLence to the Patients' Relatives Versus Standard Practice After the Death of the Patient

NCT ID: NCT02861625

Last Updated: 2020-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

432 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-24

Study Completion Date

2022-06-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this randomized multicenter study is to evaluate the impact in offering the condolence letter to the family caregivers (indicated as the reliable person by the patient himself at each hospitalization) and a bereavement consultation with the reference physician.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hypothesis is that offering the opportunity to clarify questions about the patients' terminal care will influence positively the grieving process. In particular, the study team hypothesized that psychological morbidity will be reduced (main objective) as well as some aspects of QOL (secondary objective). It is also assumed that the situations of conflict (solicitations for medical records, number of legal procedures) will be reduced.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caregivers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

letter of condolence offering to the reliable person a post-death consultation with the reference physician (sent between J15 and J30 post death)

Letter of condolence and post-death medical consultation

Intervention Type BEHAVIORAL

Process of sending a letter of condolence with consultation proposition.

Group B

no intervention, i.e without a letter of condolence proposing a consultation with the reference physician

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Letter of condolence and post-death medical consultation

Process of sending a letter of condolence with consultation proposition.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient died in the institution
* Patient for which the reliable person has been identified
* Acceptation of the reference physician to send a letter of condolence with the proposed consultation

Exclusion Criteria

* The physician already met with the caregiver after the patient's death
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Paoli-Calmettes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gwenaelle Gravis, MS

Role: PRINCIPAL_INVESTIGATOR

Institut Paoli-Calmettes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Paoli Calmettes

Marseille, Bouches Du Rhone, France

Site Status RECRUITING

GRAVIS

Marseille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dominique Genre, MD

Role: CONTACT

0033491223778

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dominique GENRE, MD

Role: primary

33 4 91 22 37 78

GRAVIS Gwenaëlle, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CONDOL01-IPC 2015-006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Loneliness as Risk Factor for Dementia
NCT07211945 NOT_YET_RECRUITING
Advanced Dementia and End-of-life
NCT03548142 COMPLETED NA
The Aarhus Bereavement Study
NCT03049007 ACTIVE_NOT_RECRUITING
Enhancing Palliative Care in ICU
NCT06605079 RECRUITING NA